Si-Bone (SIBN) Receivables - Other (2021 - 2022)
Si-Bone (SIBN) recorded quarterly Receivables - Other of $200000.0 in Q4 2022, down 33.33% quarter-over-quarter from $300000.0 in Q4 2021, and down 33.33% on a YoY basis from $300000.0 in Q4 2021.
Si-Bone (SIBN) Receivables - Other (2021 - 2022) Analysis & Trends
Si-Bone's Receivables - Other history runs 2 years deep, the most recent figure standing at $200000.0 for Q4 2022.
- In Q4 2022, Receivables - Other fell 33.33% year-over-year to $200000.0; the TTM figure through Dec 2022 stood at $200000.0 (down 33.33% YoY), while the FY2022 annual figure was $200000.0, down 33.33% from the prior year.
- Receivables - Other was $200000.0 for Q4 2022 at Si-Bone, down from $300000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $300000.0 in Q4 2021 to a low of $200000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Si-Bone | 676.10 Mn | 535.98 Mn | 41.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 200,000.00 |
| Dec 31, 2022 | 200,000.00 |
| Dec 31, 2021 | 300,000.00 |
| Dec 31, 2021 | 300,000.00 |